Generative artificial intelligence (AI) solutions are key to a major transformation in pharmaceutical companies. These companies rely on consulting firms that use the power of AI to identify market gaps. They assist pharma companies in rethinking their data strategies to create competitive differentiation. The idea is to build an economic MOAT for continuous learning and adaptability.
What are the existing challenges hindering digital transformation in pharma?
<!-- /wp:heading --> <!-- wp:paragraph -->
The pharmaceutical industry has long depended on traditional data sources across all business functions, including research, manufacturing, marketing and distribution. Data is central to developing successful drugs and treatments. However, relying on only internal datasets comes with limitations. It is important to integrate third-party syndicated data to improve organizational operational inefficiencies, drug development timelines and market access planning. This integration helps in the digital transformation pharma.
Solutions offered by consulting firms using AI capabilities
<!-- /wp:heading --> <!-- wp:heading -->
Novel solutions with multi-model data
<!-- /wp:heading --> <!-- wp:paragraph -->
Consulting firms use multi-model data to offer novel solutions to pharmaceuticals. Generative AI has the capability to help these companies accelerate market research that aids in the drug development process. The multi-model data combines structured and unstructured data to build metadata. This changes how these companies collect, collate, format and access data. It is a big move to refine the research and development infrastructure of pharma companies.
<!-- /wp:paragraph --> <!-- wp:heading -->
Build search capabilities
<!-- /wp:heading --> <!-- wp:paragraph -->
Consulting firms help build advanced search capabilities for all stakeholders in pharmaceutical companies. This is immensely helpful when dealing with large data volumes. A large pool of data helps in different stages, such as research, clinical trial and marketing. However, there is a requirement to combine business technology and organizational processes to improve search capabilities.
<!-- /wp:paragraph --> <!-- wp:paragraph -->
For example, generative AIin marketing go hand-in-hand when it comes to delivering personalized customer engagement, generating actionable insights from large datasets and enabling faster decision-making in pharma companies.
<!-- /wp:paragraph --> <!-- wp:paragraph -->
Consulting firms help pharma companies with purpose-built AI solutions for dynamic applications, such as research alignment, drug manufacturing optimization and use of commercial data for better contextualization. The data strategy revolves around data uniqueness, an agile approach and the use of a combination of first-, second and third-party data. This is a long-term strategic move to connect the broken chains in the pharmaceutical industry for faster and more efficient drug manufacturing that caters to the market needs.
